National Information Campaign Revealed Disease Characteristic and Burden in Adult Patients Suffering from Atopic Dermatitis

被引:8
|
作者
Gori, Niccolo [1 ,2 ]
Chiricozzi, Andrea [1 ,2 ]
Marsili, Franco [3 ]
Ferrucci, Silvia Mariel [4 ]
Amerio, Paolo [5 ]
Battarra, Vincenzo [6 ]
Campitiello, Salvatore [7 ]
Castelli, Antonio [8 ]
Congedo, Maurizio [9 ]
Corazza, Monica [10 ]
Cristaudo, Antonio [11 ]
Fabbrocini, Gabriella [12 ]
Girolomoni, Giampiero [13 ]
Malara, Giovanna [14 ]
Micali, Giuseppe [15 ]
Palazzo, Giovanni [16 ]
Parodi, Aurora [17 ]
Patrizi, Annalisa [18 ]
Pellacani, Giovanni [19 ]
Pigatto, Paolo [20 ]
Provenzano, Eugenio [21 ]
Quaglino, Pietro [22 ]
Romanelli, Marco [23 ]
Rossi, Mariateresa [24 ]
Savoia, Paola [25 ]
Peris, Ketty [1 ,2 ]
机构
[1] Fdn Policlin Univ Agostino Gemelli, Dipartimento Sci Med Chirurg, UOC Dermatol, IRCCS, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dipartimento Med Chirurg Traslaz, Dermatol, I-00168 Rome, Italy
[3] Versilia Hosp, Dermatol Unit, ASL 12, I-55049 Lido Di Camaiore, Italy
[4] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, I-20122 Milan, Italy
[5] Univ G dAnnunzio, Dept Med & Aging Sci, Dermatol Clin, I-66100 Chieti, Italy
[6] AORN St Anna & San Sebastiano, Unit Dermatol, I-81100 Caserta, Italy
[7] ASL Salerno, Osped Tortora Pagani, UOC Dermatol, I-84016 Salerno, Italy
[8] San Donato Hosp, Dermatol Unit, ASL 8, I-52100 Arezzo, Italy
[9] Vito Fazzi Hosp, Sect Dermatol, Piazza Filippo Muratore, I-73100 Lecce, Italy
[10] Univ Ferrara, Dept Med Sci, Sect Dermatol & Infect Dis, I-44121 Ferrara, Italy
[11] Ist Dermatol San Gallicano IRCSS, IFO, I-00100 Rome, Italy
[12] Univ Naples Federico II, Dept Clin Med & Surg, I-80131 Naples, Italy
[13] Univ Verona, Dept Med, Sect Dermatol & Venereol, I-37129 Verona, Italy
[14] Grande Osped Metropolitano Bianchi Melacrino Mor, Struttura Complessa Dermatol, I-89129 Reggio Di Calabria, Italy
[15] Univ Catania, Dermatol Clin, I-95123 Catania, Italy
[16] Osped Distrettuale Tinchi, Ambulatorio Dermatol, I-75015 Pisticci, Italy
[17] Univ Genoa, Osped, Policlin San Martino IRCCS, DiSSal Sect Dermatol, I-16132 Genoa, Italy
[18] Univ Bologna, Dept Expt Diagnost & Specialty Med, Div Dermatol, I-40138 Bologna, Italy
[19] Sapienza Univ Rome, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Dermatol Clin, I-00161 Rome, Italy
[20] IRCCS Osped Ortped Galeazzi, Dept Med Surg & Odntiatr Sci, I-20161 Milan, Italy
[21] Mariano Santo Hosp, Unit Dermatol, I-87100 Cosenza, Italy
[22] Univ Turin, Dept Med Sci, Dermatol Clin, I-10121 Turin, Italy
[23] Univ Pisa, Dermatol Dept, Via Roma 67, I-56126 Pisa, Italy
[24] Univ Brescia, Dept Dermatol, I-25121 Brescia, Italy
[25] Univ Piemonte Orientale, Dept Hlth Sci, Via Solaroli 17, I-28100 Novara, Italy
关键词
atopic dermatitis; information campaign; early diagnosis; MANAGEMENT; DUPILUMAB; MODERATE; DERMATOLOGY; GUIDELINES; DIAGNOSIS; CONSENSUS; CRITERIA; CHILDREN; ECZEMA;
D O I
10.3390/jcm11175204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atopic dermatitis (AD) is a common inflammatory skin disease often associated with a significant impairment in the quality of life of affected patients. The Italian Society of Dermatology and Venereology (SIDeMaST) planned a national information campaign, providing direct access to 27 dermatologic centers dedicated to the management of AD. The aim of this study aimed was to outline critical aspects related to AD in the general population. Overall, 643 adult subjects were included in this study, and in 44.2% (284/643) of cases, a diagnosis of AD was confirmed, whereas about 55% of subjects were affected by other pruritic cutaneous diseases. Higher intensity of pruritus and sleep disturbance, as well as an increased interference in sport, work, and social confidence was reported in the AD group compared to the non-AD group. In the AD subgroup, the mean duration of disease was of 15.3 years, with a mean eczema area and severity index (EASI) score of 11.2, and investigator global assessment (IGA) score of 1.9 and an itch numeric rating scale (NRS) of 6.9. Almost 32% of patients were untreated, either with topical or systemic agents, whereas 44.3% used routine topical compounds (topical corticosteroids and calcineurin inhibitors), and only 7.0% of patients were systemically treated. Only 2.8% of patients reported complete satisfaction with the treatment received for AD to date. This study reveals a profound unmet need in AD, showing a poorly managed and undertreated patient population despite a high reported burden of disease. This suggests the usefulness of information campaigns with the goal of improving patient awareness regarding AD and facilitating early diagnosis and access to dedicated healthcare institutions.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] THE MENTAL HEALTH BURDEN OF ATOPIC DERMATITIS FROM AN INTERNATIONAL SURVEY OF PATIENTS
    Cich, Iona
    Capozza, Korey
    Chong, Albert
    Schwartz, Alan
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 49 - 49
  • [32] Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit
    Christine Blome
    Marc A. Radtke
    Leah Eissing
    Matthias Augustin
    American Journal of Clinical Dermatology, 2016, 17 : 163 - 169
  • [33] Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit
    Blome, Christine
    Radtke, Marc A.
    Eissing, Leah
    Augustin, Matthias
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2016, 17 (02) : 163 - 169
  • [34] Evaluation of Peripheral Blood Eosinophilia in Adolescent and Adult Patients Suffering from Atopic Dermatitis and the Relation to the Occurrence of Allergy to Aeroallergens
    Celakovska, Jarmila
    Bukac, Josef
    Ettler, Karel
    Vaneckova, Jaroslava
    Krcmova, Irena
    Ettlerova, Kvetuse
    Krejsek, Jan
    INDIAN JOURNAL OF DERMATOLOGY, 2019, 64 (01) : 34 - 40
  • [35] Patient Burden is Associated with Alterations in Quality of Life in Adult Patients with Atopic Dermatitis: Results from the ECLA Study
    Misery, Laurent
    Seneschal, Julien
    Reguiai, Ziad
    Merhand, Stephanie
    Heas, Stephane
    Huet, Flavien
    Taieb, Charles
    Ezzedine, Khaled
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 (07) : 713 - 714
  • [36] Impact of day-to-day sleep disruption on the burden of disease in moderate-severe adult atopic dermatitis patients
    Pierce, E.
    Kleyn, C. E.
    Grond, S.
    Austin, J.
    Reed, C.
    Staender, S.
    Fotiou, K.
    ALLERGOLOGIE, 2022, 45 (08) : 622 - 623
  • [37] Treatment of adult atopic dermatitis patients according to disease characteristics and demographics
    Thyssen, Jacob P.
    Andersen, Yuki M. F.
    Vittrup, Ida
    Pierce, Evangeline
    DeLozier, Amy
    Egeberg, Alexander
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [38] Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis Registry
    Silverberg, Jonathan I.
    Pierce, Evangeline
    Feely, Meghan
    Atwater, Amber Reck
    Schrader, Amy
    Jones, Eric A.
    Dave, Swapna S.
    Simpson, Eric L.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [39] Impact of day-to-day sleep disruption on the burden of disease in moderate-severe adult atopic dermatitis patients
    Pierce, Evangeline
    Kleyn, C. Elise
    Grond, Susanne
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB67 - AB67
  • [40] Characterization of disease burden and comorbidities in a large, real-world cohort of patients with atopic dermatitis: the CorEvitas Atopic Dermatitis Registry
    Silverberg, Jonathan I.
    Cronin, Angel
    Jones, Eric A.
    Dave, Swapna S.
    McLean, Robert R.
    Greenberg, Jeffrey
    Strober, Bruce
    Bieber, Thomas
    Gooderham, Melinda
    Paller, Amy S.
    Simpson, Eric L.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E84 - E85